[go: up one dir, main page]

MX2012008055A - Agente profilactico o de mejoramiento para la pigmentacion. - Google Patents

Agente profilactico o de mejoramiento para la pigmentacion.

Info

Publication number
MX2012008055A
MX2012008055A MX2012008055A MX2012008055A MX2012008055A MX 2012008055 A MX2012008055 A MX 2012008055A MX 2012008055 A MX2012008055 A MX 2012008055A MX 2012008055 A MX2012008055 A MX 2012008055A MX 2012008055 A MX2012008055 A MX 2012008055A
Authority
MX
Mexico
Prior art keywords
sub
carbon atoms
pigmentation
preventing
group
Prior art date
Application number
MX2012008055A
Other languages
English (en)
Inventor
Chihiro Kondo
Takashi Yamasaki
Yuko Saitoh
Original Assignee
Pola Chem Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chem Ind Inc filed Critical Pola Chem Ind Inc
Publication of MX2012008055A publication Critical patent/MX2012008055A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/17—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing carboxyl groups bound to the carbon skeleton
    • C07C309/18—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing carboxyl groups bound to the carbon skeleton containing amino groups bound to the same carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un objetivo de la presente invención es proporcionar un agente profiláctico o de mejoramiento para la pigmentación que tiene una estructura novedosa y una preparación externa para la piel que contiene el mismo como un componente. El objetivo se logra al proporcionar un agente profiláctico o de mejoramiento para la pigmentación que comprende un compuesto representado por la siguiente fórmula general (1), un isómero del mismo y/o una sal farmacológicamente aceptable del mismo y una preparación externa para la piel que contiene el mismo como un componente: (Ver Formula) [en donde R1 representa un átomo de hidrógeno o un grupo alquilo de cadena lineal o ramificada que tiene de 1 a 8 átomo(s) de carbono; R2 representa un átomo de hidrógeno, un grupo hidrocarburo alifático sustituido o no sustituido que tiene de 1 a 8 átomo(s) de carbono, un grupo aromático sustituido o no sustituido, un grupo aromático fusionado policíclico sustituido o no sustituido, o un grupo heterocíclico o no sustituido que tiene de 5 a 12 átomos de carbono; R3 representa un grupo aromático sustituido o no sustituido, un grupo aromático fusionado policíclico sustituido o no sustituido, o un grupo heterocíclico sustituido o no sustituido que tiene de 5 a 15 átomos de carbono; n representa un número entero de 1 o 2; y m representa un número entero de 0 a 3].
MX2012008055A 2010-01-12 2011-01-12 Agente profilactico o de mejoramiento para la pigmentacion. MX2012008055A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010003785 2010-01-12
PCT/JP2011/050314 WO2011087006A1 (ja) 2010-01-12 2011-01-12 色素沈着予防又は改善剤

Publications (1)

Publication Number Publication Date
MX2012008055A true MX2012008055A (es) 2012-08-01

Family

ID=44304280

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012008055A MX2012008055A (es) 2010-01-12 2011-01-12 Agente profilactico o de mejoramiento para la pigmentacion.

Country Status (17)

Country Link
US (1) US9066914B2 (es)
EP (1) EP2524686B1 (es)
JP (1) JP5671483B2 (es)
KR (1) KR101871004B1 (es)
CN (1) CN102686213B (es)
AU (1) AU2011206133B2 (es)
BR (1) BR112012017157B1 (es)
CA (1) CA2786649C (es)
ES (1) ES2634489T3 (es)
IL (1) IL220850B (es)
MX (1) MX2012008055A (es)
MY (1) MY160253A (es)
RU (1) RU2553352C2 (es)
SG (1) SG182415A1 (es)
TW (1) TWI473623B (es)
UA (1) UA111324C2 (es)
WO (1) WO2011087006A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5666158B2 (ja) * 2010-03-31 2015-02-12 ポーラ化成工業株式会社 肌荒れ予防又は改善剤
JP5669436B2 (ja) * 2010-05-18 2015-02-12 ポーラ化成工業株式会社 組成物
JP6086706B2 (ja) * 2012-11-14 2017-03-01 ポーラ化成工業株式会社 高い紫外線吸収効果を有する皮膚外用組成物
JP6113484B2 (ja) * 2012-12-12 2017-04-12 ポーラ化成工業株式会社 美白成分を含有する多価アルコール相組成物
SG11201608225PA (en) * 2014-04-03 2016-11-29 Pola Chem Ind Inc Melanogenesis inhibitor comprising d-pantothenyl alcohol, and skin-whitening cosmetic containing same melanogenesis inhibitor
WO2022250348A1 (ko) * 2021-05-26 2022-12-01 경북대학교 산학협력단 시스테인 유도체의 피부 미백 용도

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05117295A (ja) 1991-10-23 1993-05-14 Ajinomoto Co Inc 香粧品素材及び外用医薬基剤
TW544310B (en) 1998-04-02 2003-08-01 Ajinomoto Kk Amino acid derivatives and anti-inflammatory agents
JPH11343235A (ja) 1998-04-02 1999-12-14 Ajinomoto Co Inc アミノ酸誘導体および炎症因子活性化抑制剤
CN1261449C (zh) * 1999-04-26 2006-06-28 味之素株式会社 促黑素细胞激素抑制剂
US6495126B1 (en) 1999-07-20 2002-12-17 Mary Kay Inc. Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
FR2813189B1 (fr) 2000-08-31 2003-02-28 Oreal Creme cosmetique moussante pour le traitement des peaux grasses
DK1516083T3 (da) 2002-06-24 2008-08-04 Croda Int Plc Fremgangsmåde til rensning af tekstiler
ITMI20021405A1 (it) 2002-06-25 2003-12-29 Zambon Spa Composizioni farmaceutiche per il trattamento di infezioni da patogeni dell'apparato respiratorio
JP4667875B2 (ja) 2002-12-27 2011-04-13 第一三共ヘルスケア株式会社 美白用組成物
JP2004323401A (ja) 2003-04-23 2004-11-18 Mikimoto Pharmaceut Co Ltd 皮膚外用剤
US20070042997A1 (en) * 2003-07-16 2007-02-22 Akiko Itai Medicament for treatment of dermal pigmentation
JP2005162699A (ja) 2003-12-04 2005-06-23 Kao Corp 毛髪用還元性水性組成物
JP4341501B2 (ja) * 2004-08-10 2009-10-07 東亞合成株式会社 チロシナーゼ活性阻害剤
KR100708613B1 (ko) * 2006-01-31 2007-04-18 (주)아모레퍼시픽 페닐 이미다졸 술폰아미드 유도체 및 이의 제조방법, 및 이를 함유하는 피부 미백용 화장료 조성물
JP2008088113A (ja) 2006-10-03 2008-04-17 Ss Pharmaceut Co Ltd 美白組成物
JP2008105976A (ja) * 2006-10-24 2008-05-08 Shinichiro Isobe 化粧用組成物
ES3029483T3 (en) * 2008-09-17 2025-06-24 Endocyte Inc Folate receptor binding conjugates of antifolates
CA2742909C (en) * 2008-11-19 2017-12-19 Pola Chemical Industries Inc. Anti-wrinkle agents

Also Published As

Publication number Publication date
CA2786649C (en) 2017-09-05
BR112012017157A2 (pt) 2018-06-19
HK1173368A1 (en) 2013-05-16
TWI473623B (zh) 2015-02-21
AU2011206133A1 (en) 2012-08-16
JPWO2011087006A1 (ja) 2013-05-20
TW201132361A (en) 2011-10-01
IL220850A0 (en) 2012-09-24
UA111324C2 (uk) 2016-04-25
CA2786649A1 (en) 2011-07-21
ES2634489T3 (es) 2017-09-28
RU2012134454A (ru) 2014-02-20
CN102686213B (zh) 2014-11-12
US20120282203A1 (en) 2012-11-08
WO2011087006A1 (ja) 2011-07-21
SG182415A1 (en) 2012-08-30
US9066914B2 (en) 2015-06-30
CN102686213A (zh) 2012-09-19
BR112012017157B1 (pt) 2018-12-11
AU2011206133B2 (en) 2014-09-18
EP2524686B1 (en) 2017-06-21
EP2524686A1 (en) 2012-11-21
KR20120113262A (ko) 2012-10-12
MY160253A (en) 2017-02-28
JP5671483B2 (ja) 2015-02-18
RU2553352C2 (ru) 2015-06-10
IL220850B (en) 2018-11-29
EP2524686A4 (en) 2013-05-29
KR101871004B1 (ko) 2018-06-25

Similar Documents

Publication Publication Date Title
EP3051350A3 (en) Alcoholic compound and method for producing alcoholic compound
NZ596615A (en) Substituted isoquinoline derivative
UA105671C2 (uk) Фармацевтична композиція, яка містить похідне хіноліну
MX2012008055A (es) Agente profilactico o de mejoramiento para la pigmentacion.
PH12012501711A1 (en) [5,6] heterocyclic compound
WO2008108378A3 (en) Bicyclic oxomorpholine derivative
MX2013002558A (es) Derivado de imidazol de heteroanillo fusionado que tiene efecto de activacion de proteina cinasa activada por monofosfato de adenosina (amk).
MX2011009423A (es) Compuesto de piperazina capaz de inhibir prostaglandina d sintasa.
SG196826A1 (en) Combinations comprising methotrexate and dhodh inhibitors
MY149180A (en) Uracil compound having inhibitor activity on human deoxyuridine triphosphatase or salt thereof
TN2011000422A1 (en) Benzofuran derivatives
IN2014DN10723A (es)
TW201129564A (en) Diphenylpyrazolopyridine derivatives, preparation thereof and therapeutic use thereof
MX2010008864A (es) Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor adrenergico beta 2.
MY179437A (en) Preventing or ameliorating agent for pigmentation
MX2013007938A (es) Compuesto biciclico novedoso o sal del mismo.
AU2006325931A8 (en) Amine compound and use thereof for medical purposes
MX2013007296A (es) Derivado novedoso de isoquinolina sustituido.
PH12014502663A1 (en) Aromatic heterocyclic derivative and pharmaceutical
GB2470170A (en) Dithienothiophene derivatives
UA111950C2 (uk) Гетероциклічні сполуки для лікування або профілактики розладів, викликаних зниженою нейротрансмісією серотоніну, норепінефрину або допаміну
MX2009011449A (es) Agente terapeutico o profilactico para disquinesia.
PH12013500605B1 (en) 4-(methylaminophenoxy)pyrdin-3-yl-benzamide derivatives for treating cancer
PH12013500823A1 (en) 22-yne-vitamin d3 derivative
MX362478B (es) Derivado de benzoazepina novedoso y uso medico del mismo.

Legal Events

Date Code Title Description
FG Grant or registration